Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bloomingdale

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Pharmaceutical Research|January 9, 2019
Machine Learning Models for the Prediction of Chemotherapy-Induced Peripheral NeuropathyPeter Bloomingdale, Donald E Mager
Journal of Pharmacokinetics and Pharmacodynamics|January 8, 2018
Boolean network modeling in systems pharmacologyPeter Bloomingdale, Van Anh Nguyen, Jin Niu, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 15, 2021
Quantitative systems pharmacology in neuroscience: Novel methodologies and technologiesPeter Bloomingdale, Tatiana Karelina, Murat Cirit, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 11, 2023
Microglial roles in Alzheimer's disease: An agent-based model to elucidate microglial spatiotemporal response to beta-amyloidCatherine Weathered, Sophia Bardehle, Choya Yoon, et al.
Current Opinion in Toxicology|January 9, 2018
Quantitative systems toxicologyPeter Bloomingdale, Conrad Housand, Joshua F Apgar, et al.
Frontiers in Pharmacology|September 19, 2022
PBPK-PD modeling for the preclinical development and clinical translation of tau antibodies for Alzheimer's diseasePeter Bloomingdale, Daniela Bumbaca-Yadav, Jonathan Sugam, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 11, 2021
Minimal brain PBPK model to support the preclinical and clinical development of antibody therapeutics for CNS diseasesPeter Bloomingdale, Suruchi Bakshi, Christian Maass, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2022
Hallmarks of neurodegenerative disease: A systems pharmacology perspectivePeter Bloomingdale, Tatiana Karelina, Vidya Ramakrishnan, et al.
Frontiers in Pharmacology|February 7, 2022
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic PainPeter Bloomingdale, Cristina Meregalli, Kevin Pollard, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Pharmaceutical Research|January 9, 2019
Machine Learning Models for the Prediction of Chemotherapy-Induced Peripheral NeuropathyPeter Bloomingdale, Donald E Mager
Journal of Pharmacokinetics and Pharmacodynamics|January 8, 2018
Boolean network modeling in systems pharmacologyPeter Bloomingdale, Van Anh Nguyen, Jin Niu, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 15, 2021
Quantitative systems pharmacology in neuroscience: Novel methodologies and technologiesPeter Bloomingdale, Tatiana Karelina, Murat Cirit, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 11, 2023
Microglial roles in Alzheimer's disease: An agent-based model to elucidate microglial spatiotemporal response to beta-amyloidCatherine Weathered, Sophia Bardehle, Choya Yoon, et al.
Current Opinion in Toxicology|January 9, 2018
Quantitative systems toxicologyPeter Bloomingdale, Conrad Housand, Joshua F Apgar, et al.
Frontiers in Pharmacology|September 19, 2022
PBPK-PD modeling for the preclinical development and clinical translation of tau antibodies for Alzheimer's diseasePeter Bloomingdale, Daniela Bumbaca-Yadav, Jonathan Sugam, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 11, 2021
Minimal brain PBPK model to support the preclinical and clinical development of antibody therapeutics for CNS diseasesPeter Bloomingdale, Suruchi Bakshi, Christian Maass, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2022
Hallmarks of neurodegenerative disease: A systems pharmacology perspectivePeter Bloomingdale, Tatiana Karelina, Vidya Ramakrishnan, et al.
Frontiers in Pharmacology|February 7, 2022
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic PainPeter Bloomingdale, Cristina Meregalli, Kevin Pollard, et al.
Pageof 1